Decidual Stromal Cells for graft vs host disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Nov 2021: Trial registered, NCT05132166
  2. 22 Dec 2021: Trial started, NCT05132166

The trials

NCT05132166: A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease

State
Under way
Phase
Phase 2
People
50 planned
Started
22 Dec 2021
Primary completion
26 Apr 2026
Arms
DSC
Results
None posted
  1. 24 Nov 2021: Trial registered
  2. 22 Dec 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.